Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1955 1
1956 1
1957 1
1965 1
1968 1
1970 2
1971 1
1972 1
1973 2
1974 4
1975 2
1976 4
1977 3
1978 8
1979 3
1980 7
1981 4
1982 5
1983 10
1984 16
1985 9
1986 12
1987 23
1988 43
1989 63
1990 95
1991 163
1992 123
1993 140
1994 136
1995 136
1996 158
1997 109
1998 117
1999 119
2000 86
2001 101
2002 76
2003 64
2004 62
2005 70
2006 56
2007 59
2008 48
2009 70
2010 71
2011 66
2012 60
2013 72
2014 64
2015 66
2016 80
2017 81
2018 83
2019 94
2020 99
2021 134
2022 70
2023 110
2024 102

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

3,282 results

Results by year

Filters applied: . Clear all
Page 1
Prophylaxis Against Pneumocystis jirovecii Pneumonia in Adults.
Zhou S, Aitken SL. Zhou S, et al. JAMA. 2023 Jul 11;330(2):182-183. doi: 10.1001/jama.2023.9844. JAMA. 2023. PMID: 37358837
This JAMA Insights Clinical Update discusses current recommendations regarding prevention of Pneumocystis pneumonia in patients who are immunocompromised....
This JAMA Insights Clinical Update discusses current recommendations regarding prevention of Pneumocystis pneumonia in …
Pneumocystis jirovecii: a review with a focus on prevention and treatment.
Weyant RB, Kabbani D, Doucette K, Lau C, Cervera C. Weyant RB, et al. Expert Opin Pharmacother. 2021 Aug;22(12):1579-1592. doi: 10.1080/14656566.2021.1915989. Epub 2021 Apr 19. Expert Opin Pharmacother. 2021. PMID: 33870843 Review.
Introduction: Pneumocystis jirovecii (PJ) is an opportunistic fungal pathogen that can cause severe pneumonia in immunocompromised hosts. Risk factors for Pneumocystis jirovecii pneumonia (PJP) include HIV, organ transplant, malignancy, certain inflamm …
Introduction: Pneumocystis jirovecii (PJ) is an opportunistic fungal pathogen that can cause severe pneumonia in immunocomprom …
Consensus guidelines for diagnosis, prophylaxis and management of Pneumocystis jirovecii pneumonia in patients with haematological and solid malignancies, 2014.
Cooley L, Dendle C, Wolf J, Teh BW, Chen SC, Boutlis C, Thursky KA. Cooley L, et al. Intern Med J. 2014 Dec;44(12b):1350-63. doi: 10.1111/imj.12599. Intern Med J. 2014. PMID: 25482745 Review.
Pneumocystis jirovecii infection (PJP) is a common cause of pneumonia in patients with cancer-related immunosuppression. ...Trimethoprim-sulfamethoxazole is the drug of choice for prophylaxis and treatment, although several alternative agents are available... …
Pneumocystis jirovecii infection (PJP) is a common cause of pneumonia in patients with cancer-related immunosuppression. ...Tr …
Prophylaxis for Pneumocystis jirovecii pneumonia in patients with inflammatory bowel disease: A systematic review.
Sierra CM, Daiya KC. Sierra CM, et al. Pharmacotherapy. 2022 Nov;42(11):858-867. doi: 10.1002/phar.2733. Epub 2022 Oct 25. Pharmacotherapy. 2022. PMID: 36222368 Free PMC article. Review.
Patients with inflammatory bowel disease (IBD) are at increased risk of developing Pneumocystis jirovecii pneumonia (PJP) than the general population. Many medications utilized for the treatment of IBD affect the immune system, potentially further increasing the ris …
Patients with inflammatory bowel disease (IBD) are at increased risk of developing Pneumocystis jirovecii pneumonia (PJP) than …
Pneumocystis jiroveci.
Fishman JA. Fishman JA. Semin Respir Crit Care Med. 2020 Feb;41(1):141-157. doi: 10.1055/s-0039-3399559. Epub 2020 Jan 30. Semin Respir Crit Care Med. 2020. PMID: 32000290 Review.
Subclinical infection or colonization may occur. Pneumocystis pneumonia occurs most often within 6 months of organ transplantation and with intensified or prolonged immunosuppression, notably with corticosteroids. ...Adjunctive corticosteroids may be useful early in …
Subclinical infection or colonization may occur. Pneumocystis pneumonia occurs most often within 6 months of organ transplanta …
Primary prophylaxis of bacterial infections and Pneumocystis jirovecii pneumonia in patients with hematologic malignancies and solid tumors: 2020 updated guidelines of the Infectious Diseases Working Party of the German Society of Hematology and Medical Oncology (AGIHO/DGHO).
Classen AY, Henze L, von Lilienfeld-Toal M, Maschmeyer G, Sandherr M, Graeff LD, Alakel N, Christopeit M, Krause SW, Mayer K, Neumann S, Cornely OA, Penack O, Weißinger F, Wolf HH, Vehreschild JJ. Classen AY, et al. Ann Hematol. 2021 Jun;100(6):1603-1620. doi: 10.1007/s00277-021-04452-9. Epub 2021 Apr 13. Ann Hematol. 2021. PMID: 33846857 Free PMC article.
Hematologic and oncologic patients with chemo- or immunotherapy-related immunosuppression are at substantial risk for bacterial infections and Pneumocystis jirovecii pneumonia (PcP). As bacterial resistances are increasing worldwide and new research reshapes our und …
Hematologic and oncologic patients with chemo- or immunotherapy-related immunosuppression are at substantial risk for bacterial infections a …
Diagnosing Pneumocystis jirovecii pneumonia: A review of current methods and novel approaches.
Bateman M, Oladele R, Kolls JK. Bateman M, et al. Med Mycol. 2020 Nov 10;58(8):1015-1028. doi: 10.1093/mmy/myaa024. Med Mycol. 2020. PMID: 32400869 Free PMC article. Review.
Pneumocystis jirovecii can cause life-threatening pneumonia in immunocompromised patients. ...These techniques are very sensitive and have the potential to detect Pneumocystis life-forms in noninvasive samples such as sputum, oral washes, nasopharyngeal aspir …
Pneumocystis jirovecii can cause life-threatening pneumonia in immunocompromised patients. ...These techniques are very sensit …
Pneumocystis jirovecii pneumonia in people living with HIV: a review.
McDonald EG, Afshar A, Assiri B, Boyles T, Hsu JM, Khuong N, Prosty C, So M, Sohani ZN, Butler-Laporte G, Lee TC. McDonald EG, et al. Clin Microbiol Rev. 2024 Mar 14;37(1):e0010122. doi: 10.1128/cmr.00101-22. Epub 2024 Jan 18. Clin Microbiol Rev. 2024. PMID: 38235979 Review.
Pneumocystis jirovecii is a ubiquitous opportunistic fungus that can cause life-threatening pneumonia. People with HIV (PWH) who have low CD4 counts are one of the populations at the greatest risk of Pneumocystis jirovecii pneumonia (PCP). While guidel …
Pneumocystis jirovecii is a ubiquitous opportunistic fungus that can cause life-threatening pneumonia. People with HIV (PWH) w …
Pneumocystis jirovecii pneumonia prophylaxis in immunocompromised patients with systemic autoimmune diseases.
Braga BP, Prieto-González S, Hernández-Rodríguez J. Braga BP, et al. Med Clin (Barc). 2019 Jun 21;152(12):502-507. doi: 10.1016/j.medcli.2019.01.010. Epub 2019 Mar 8. Med Clin (Barc). 2019. PMID: 30853123 Review. English, Spanish.
Pneumocystis jirovecii (P. jirovecii) causes a potentially fatal pneumonia in immunocompromised individuals (Pneumocystis pneumonia or PcP), particularly in HIV-infected patients and those treated with immunosuppressive drugs, such as transplant patien …
Pneumocystis jirovecii (P. jirovecii) causes a potentially fatal pneumonia in immunocompromised individuals (Pneumocystis …
Pneumocystis jirovecii Pneumonia in the Non-HIV-Infected Population.
Avino LJ, Naylor SM, Roecker AM. Avino LJ, et al. Ann Pharmacother. 2016 Aug;50(8):673-9. doi: 10.1177/1060028016650107. Epub 2016 May 30. Ann Pharmacother. 2016. PMID: 27242349 Review.
OBJECTIVE: Summarize data on the pathophysiology, treatment, and prevention options for non-AIDS immunocompromised patients who have Pneumocystis jirovecii pneumonia (PJP); review the epidemiology of patients presenting with PJP; and discuss the first and sec …
OBJECTIVE: Summarize data on the pathophysiology, treatment, and prevention options for non-AIDS immunocompromised patients who have …
3,282 results